Wednesday, May 18, 2022

Latest:

Healthy Habits: Dr. Felicia Skelton-Dudley starts her day with quiet reflection and practices yoga
Dr. Susan Rosenberg elected to AAAS Board of Directors
Spring cleaning safety tips
Social burnout post-pandemic
Alone at the hands of healthcare: hospital visitor policies during the COVID-19 pandemic

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Akt pathway

From The Labs

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

From The Labs

CD44s, not CD44v, contributes to cancer survival

July 25, 2017May 11, 2018Akt pathway, alternative splicing, cancer survival, CD44, EGFR signaling

Cells may stray away from their normal function in a number of ways. For example, it’s been known for some time that in a number

From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.